Back to Authors

Hammell, Molly

0000-0003-0405-8392

Mayo Clinic

NYU Langone Health

Citations 1

TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in amyotrophic lateral sclerosis and frontotemporal dementia
Arnold, Frederick J. , Cui, Ya , Colwin, Michael R., Stockford, Cameron , Jawahar, Vidhya Maheswari, Jansen‐West, Karen , Gulia, Ravinder , Gou, Yunzi , Tam, Oliver H. , Situ, W., Cazarez, Saira L, Zandi, Ali Shahidi , Ehsani, Kean C. K., Howard, Sierra, Prudencio, Mercedes , Petrucelli, Leonard , Spada, Albert R. La , Maheswari Jawahar, Vidhya, Jansen-West, Karen, Prudencio, Mercedes , Michels, Sebastian , Ye, Wenbin , Bharathi, Vidhya , Philippe, Julien, Menon, Sneha, Cazarez, Saira L., Zandi, Aryan, Dickson, Dennis W. , Hammell, Molly , Li, Wei

Journal of Clinical Investigation | June 1, 2025 | Volume: 135 | Issue: 11 | Pages: No page available

10.1172/jci182088 Get It

Nuclear clearance and cytoplasmic aggregation of TAR DNA-binding protein 43 (TDP-43) are observed in many neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Although TDP-43 dysregulation of splicing has emerged as a key event in these diseases, TDP-43 can also regulate polyadenylation; yet this has not been adequately studied. Here, we applied the dynamic analysis of polyadenylation from an RNA-Seq (DaPars) tool to ALS/FTD transcriptome datasets and report extensive alternative polyadenylation (APA) upon TDP-43 alteration in ALS/FTD cell models and postmortem ALS/FTD neuronal nuclei. Importantly, many identified APA genes highlight pathways implicated in ALS/FTD pathogenesis. To determine the functional relevance of APA elicited by TDP-43 nuclear depletion, we examined microtubule affinity regulating kinase 3 (MARK3). Nuclear loss of TDP-43 yielded increased expression of MARK3 transcripts with longer 3′ UTRs, corresponding with a change in the subcellular distribution of MARK3 and increased neuronal tau S262 phosphorylation. Our findings define changes in polyadenylation site selection as a previously understudied feature of TDP-43–driven disease pathology in ALS/FTD and highlight a potentially important mechanistic link between TDP-43 dysfunction and tau regulation.